Diabetic Neuropathy Treatment Market by Disorder (Peripheral, Autonomic, Proximal, and Focal Neuropathy), Treatment (Drugs, Radiotherapy, and Physiotherapy), and Distribution Channels (Hospitals, Clinics, and Pharmacy) - Global Opportunity Analysis and Industry Forecast, 2019-2026

Healthcare	LI_182578	Pages: NA	Jan 2020 \| 1961 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Diabetic neuropathy is a nerve damaging disorder associated with diabetes mellitus. Patients suffering from diabetes since a long time are prone to nerve damages throughout the body, as the symptoms of diabetic neuropathies cannot be diagnosed at an earlier stage. Although there is no cure for diabetic neuropathy, it can be suppressed or prevented using various treatment modalities.

The global diabetic neuropathy market is driven by increase in prevalence of diabetes due to sedentary lifestyle, rise in obese population due to improper diet, and growth in awareness regarding diagnosis & treatment of diabetes. However, high cost of treatment for diabetic neuropathy and side effects associated with the drugs hinder the market growth. On the contrary, rise in demand for the development of better neuropathy drugs is expected to present numerous opportunities for the market growth in the near future.

The global diabetic neuropathy market is segmented on the basis of disorder, treatment, distribution channel, and region. On the basis of disorder, it is divided into peripheral, autonomic, proximal, and focal neuropathy. Based on treatment, it is divided into drugs, radiotherapy, physiotherapy, and others. Based on distribution channel, it is classified into hospitals, clinics, and pharmacy. The market is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

The key companies profiled in this report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Johnson & Johnson, GlaxoSmithKline plc., Lupin Limited, Glenmark Pharmaceuticals Limited, Depomed, Inc., Astellas Pharma Inc., and Pfizer Inc.

Key Benefits

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market by type assists in understanding the regional trends.
Key players and their strategies have been analyzed to understand the competitive outlook of the market.

Diabetic Neuropathy Treatment Market Key Segments

By Disorder

Peripheral Neuropathy
Autonomic Neuropathy
Proximal Neuropathy
Focal Neuropathy

By Treatment

Drugs
- Analgesics
  - Topical
    - Capsaicin
    - Others
  - Opioid
    - Morphine
    - Others
  - NSAIDs (Non-steroidal Anti-inflammatory Drugs)
    - Ibuprofen
    - Naproxen
    - Others
- Anti-depressants
  - TCAs (Tricyclic Anti-depressants)
    - Amitriptyline
    - Imipramine
    - Others
  - SNRIs (Selective Nor-epinephrine Reuptake Inhibitors)
    - Duloxetine
    - Others
  - SSRIs (Selective Serotonin Reuptake Inhibitors)
    - Citalopram
    - Paroxetin
    - Others
- Anti-convulsant
  - Gabapentin
  - Pregabalin
  - Topiramate
  - Others
- Other Drugs
Radiotherapy
Physiotherapy
Others

By Distribution Channel

Hospitals
Clinics
Pharmacy

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,041 Data Pack/Excel ~~$3,840~~ $3,379 Single User License ~~$5,370~~ $4,726 Five User License ~~$6,450~~ $5,676 Enterprise User License ~~$8,995~~ $7,916

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com